Current Status and Prospects of Targeted Therapy for Osteosarcoma

Area of Science:

• Oncology
• Bone Cancer Research
• Translational Medicine

Background:

• Osteosarcoma (OS) is a highly malignant bone tumor characterized by frequent metastasis and poor patient prognosis.
• Current treatments including surgery, chemotherapy, and immunotherapy have limited efficacy in improving survival rates.
• The underlying mechanisms of OS progression and metastasis remain incompletely understood, posing a significant challenge to effective treatment.

Purpose of the Study:

• To provide a comprehensive overview of current and emerging treatment modalities for osteosarcoma.
• To discuss the role and potential of targeted therapy in managing osteosarcoma.
• To explore novel technologies and therapeutic targets for osteosarcoma treatment.

Main Methods:

• Literature review of existing research on osteosarcoma treatments.
• Analysis of current therapeutic strategies: surgery, chemotherapy, and immunotherapy.
• Discussion of targeted therapy, including key molecular targets and innovative treatment technologies.

Main Results:

• Current standard treatments for osteosarcoma demonstrate limited effectiveness.
• Targeted therapy is emerging as a crucial and potentially irreplaceable treatment strategy.
• Advancements in technology are paving the way for new and more effective osteosarcoma interventions.

Conclusions:

• Improving osteosarcoma patient survival remains a significant clinical challenge.
• Targeted therapy, alongside new technologies, offers substantial promise for future osteosarcoma treatment.
• Further research into OS mechanisms and targeted approaches is essential for clinical advancement.